🇺🇸 FDA
Patent

US 6500798

Use of colostrinin, constituent peptides thereof, and analogs thereof, as oxidative stress regulators

expired A61KA61K38/07A61K38/08

Quick answer

US patent 6500798 (Use of colostrinin, constituent peptides thereof, and analogs thereof, as oxidative stress regulators) held by The Board of Regents of the University of Texas System expires Mon Dec 26 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Dec 31 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 26 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K38/07, A61K38/08, A61K38/10, A61K38/17